Chris Alderman

521 total citations
37 papers, 354 citations indexed

About

Chris Alderman is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Chris Alderman has authored 37 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Geriatrics and Gerontology, 6 papers in Economics and Econometrics and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Chris Alderman's work include Pharmaceutical Practices and Patient Outcomes (17 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Pharmaceutical studies and practices (3 papers). Chris Alderman is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (17 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Pharmaceutical studies and practices (3 papers). Chris Alderman collaborates with scholars based in Australia and Indonesia. Chris Alderman's co-authors include David I. Ben-Tovim, Karen Mack, Richard J. Burns, P. C. Blumbergs, Gillian E. Caughey, K.S. Lindsay, Catherine Hill, Michael J. Ryan, Luke E. Grzeskowiak and Rebecca Thompson and has published in prestigious journals such as Annals of Pharmacotherapy, Journal of Clinical Pharmacy and Therapeutics and Therapeutic Advances in Drug Safety.

In The Last Decade

Chris Alderman

28 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Alderman Australia	9	80	72	68	65	51	37	354
Helen Berlie United States	11	168 2.1×	42 0.6×	19 0.3×	63 1.0×	53 1.0×	25	551
Feng-Hwa Lu Taiwan	10	76 0.9×	95 1.3×	18 0.3×	99 1.5×	30 0.6×	30	509
Jessica W. Skelley United States	11	30 0.4×	58 0.8×	15 0.2×	44 0.7×	78 1.5×	32	378
Geetha Iyer United States	9	53 0.7×	44 0.6×	19 0.3×	36 0.6×	102 2.0×	17	495
John Noviasky United States	11	37 0.5×	26 0.4×	148 2.2×	35 0.5×	60 1.2×	33	414
Tomasz Zaprutko Poland	11	21 0.3×	40 0.6×	33 0.5×	42 0.6×	28 0.5×	49	364
I fan Kuo Canada	11	59 0.7×	37 0.5×	54 0.8×	21 0.3×	12 0.2×	32	328
Sónia Silva Portugal	7	35 0.4×	27 0.4×	56 0.8×	134 2.1×	14 0.3×	16	336
J. Chris Bradberry United States	12	45 0.6×	34 0.5×	13 0.2×	77 1.2×	25 0.5×	20	382
Wayne D. Mitchell United States	11	31 0.4×	55 0.8×	75 1.1×	47 0.7×	37 0.7×	18	428

Countries citing papers authored by Chris Alderman

Since Specialization

Citations

This map shows the geographic impact of Chris Alderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Alderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Alderman more than expected).

Fields of papers citing papers by Chris Alderman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Alderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Alderman. The network helps show where Chris Alderman may publish in the future.

Co-authorship network of co-authors of Chris Alderman

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Alderman. A scholar is included among the top collaborators of Chris Alderman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Alderman. Chris Alderman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alderman, Chris. (2023). Complexity: Tending to the Medication-Related Needs of Older People. The Senior Care Pharmacist. 38(7). 260–261.

Alderman, Chris. (2022). Do Pharmacists Have a Compelling Vision for the Future?. The Senior Care Pharmacist. 37(11). 534–535.

Alderman, Chris. (2021). Multimorbidity, Consumer-Directed Care, and Drug-Related Harm. The Senior Care Pharmacist. 36(3). 125–126.

Alderman, Chris. (2021). COVID-19: We’re All in This Together ‐ Some More Than Others. The Senior Care Pharmacist. 36(8). 358–360. 1 indexed citations

Alderman, Chris. (2020). On the Pharmacy Radar: COViD-19 and Older People. The Senior Care Pharmacist. 35(5). 190–194.

Alderman, Chris. (2020). Pharmacy Education in the Time of COVID-19: In Chaos, There is Opportunity.. PubMed. 35(11). 467–468. 2 indexed citations

Alderman, Chris. (2020). Pharmacy Education in the Time of COVID-19: In Chaos, There is Opportunity. The Senior Care Pharmacist. 35(11). 467–468. 1 indexed citations

Alderman, Chris. (2020). Pharmacy Services and the Novel Coronavirus. The Senior Care Pharmacist. 35(4). 146–147. 3 indexed citations

Widodo, Widodo, et al.. (2019). Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy. Journal of Basic and Clinical Physiology and Pharmacology. 30(6). 6 indexed citations

10.

Suharjono, Suharjono, et al.. (2019). Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma. Journal of Basic and Clinical Physiology and Pharmacology. 30(6). 1 indexed citations

11.

Ardianto, Chrismawan, et al.. (2019). Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients. Journal of Basic and Clinical Physiology and Pharmacology. 30(6). 4 indexed citations

12.

Alderman, Chris, et al.. (2019). Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review. Therapeutic Advances in Drug Safety. 10. 584388945–584388945. 35 indexed citations

13.

Alderman, Chris. (2013). What should a Journal really be about? Where the JPPR came from, and Where it is going Next?. Journal of Pharmacy Practice and Research. 43(2). 93–94.

14.

Alderman, Chris. (2013). Our Duty of Care towards Older People. Journal of Pharmacy Practice and Research. 43(4). 260–260.

15.

Alderman, Chris & Michael J. Ryan. (1997). Consumer Requests for Information regarding Psychotropic Drugs: Experience from a National Medicines Phone-In. Annals of Pharmacotherapy. 31(11). 1301–1305. 7 indexed citations

16.

Alderman, Chris. (1996). Adverse Effects of the Angiotensin-Converting Enzyme Inhibitors. Annals of Pharmacotherapy. 30(1). 55–61. 70 indexed citations

17.

Alderman, Chris & K.S. Lindsay. (1996). Increased Serum Lithium Concentration Secondary to Treatment with Tiaprofenic Acid and Fosinopril. Annals of Pharmacotherapy. 30(12). 1411–1413. 9 indexed citations

18.

Alderman, Chris & Catherine Hill. (1994). Abnormal Bone Mineral Metabolism after Long-Term Anticonvulsant Treatment. Annals of Pharmacotherapy. 28(1). 47–48. 9 indexed citations

19.

Alderman, Chris, et al.. (1992). Abnormal Platelet Aggregation Associated with Fluoxetine Therapy. Annals of Pharmacotherapy. 26(12). 1517–1519. 56 indexed citations

20.

Burns, Richard J., et al.. (1990). Creutzfeldt‐Jakob disease in a recipient of human pituitary‐derived gonadotrophin. Australian and New Zealand Journal of Medicine. 20(4). 592–593. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact